362 related articles for article (PubMed ID: 15062649)
1. Early molecular and genetic determinants of primary liver malignancy.
Feitelson MA; Pan J; Lian Z
Surg Clin North Am; 2004 Apr; 84(2):339-54. PubMed ID: 15062649
[TBL] [Abstract][Full Text] [Related]
2. Genetic mechanisms of hepatocarcinogenesis.
Feitelson MA; Sun B; Satiroglu Tufan NL; Liu J; Pan J; Lian Z
Oncogene; 2002 Apr; 21(16):2593-604. PubMed ID: 11971194
[TBL] [Abstract][Full Text] [Related]
3. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
4. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
5. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
6. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA
Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus-associated multistep hepatocarcinogenesis: a stepwise increase in allelic alterations.
Lee JM; Wong CM; Ng IO
Cancer Res; 2008 Jul; 68(14):5988-96. PubMed ID: 18632655
[TBL] [Abstract][Full Text] [Related]
8. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
9. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
Pasquinelli C; Bhavani K; Chisari FV
Cancer Res; 1992 May; 52(10):2823-9. PubMed ID: 1316229
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects.
Kao JH; Chen PJ; Chen DS
Adv Cancer Res; 2010; 108():21-72. PubMed ID: 21034965
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus infection and hepatocellular carcinoma: molecular genetics and clinical perspectives.
Chen PJ; Chen DS
Semin Liver Dis; 1999; 19(3):253-62. PubMed ID: 10518305
[TBL] [Abstract][Full Text] [Related]
12. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
13. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method.
Iizuka N; Oka M; Yamada-Okabe H; Mori N; Tamesa T; Okada T; Takemoto N; Tangoku A; Hamada K; Nakayama H; Miyamoto T; Uchimura S; Hamamoto Y
Cancer Res; 2002 Jul; 62(14):3939-44. PubMed ID: 12124323
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B x antigen up-regulates vascular endothelial growth factor receptor 3 in hepatocarcinogenesis.
Lian Z; Liu J; Wu M; Wang HY; Arbuthnot P; Kew M; Feitelson MA
Hepatology; 2007 Jun; 45(6):1390-9. PubMed ID: 17539024
[TBL] [Abstract][Full Text] [Related]
15. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of HBV-associated hepatocarcinogenesis.
Guerrieri F; Belloni L; Pediconi N; Levrero M
Semin Liver Dis; 2013 May; 33(2):147-56. PubMed ID: 23749671
[TBL] [Abstract][Full Text] [Related]
17. Genetic aspects of hepatocellular carcinogenesis.
Ozturk M
Semin Liver Dis; 1999; 19(3):235-42. PubMed ID: 10518303
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
[TBL] [Abstract][Full Text] [Related]
19. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
Kim DG
Methods Mol Biol; 2006; 317():141-55. PubMed ID: 16264227
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
